Observational analysis evaluates clinical outcomes in transthyretin amyloid cardiomyopathy, highlighting prognostic impacts of atrial arrhythmias.
Key Points
To investigate the association between atrial fibrillation or flutter and adverse clinical outcomes in individuals with transthyretin amyloid cardiomyopathy.
Evaluated patients with transthyretin amyloid cardiomyopathy for co-occurring atrial fibrillation or atrial flutter.
Tracked downstream clinical outcomes and disease progression linked to these abnormal heart rhythms.
Investigated the prognostic impact of supraventricular arrhythmias on overall morbidity and mortality in transthyretin amyloid cardiomyopathy.
Detailed quantitative event rates and hazard ratios were not reported in the available abstract text.